Papuloerythematous rash due to intralymphatic cutaneous metastasis of cancer.
Miyoshi
Isao
I
Department of Medicine, Kochi University School of Medicine, Kochi.
Saito
Tsuyako
T
Bandobashi
Kentaro
K
Kodama
Hajime
H
Ohtsuki
Yuji
Y
Taguchi
Hirokuni
H
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D001706:Biopsy; D016190:Carboplatin / Q000008:administration & dosage; D002277:Carcinoma / Q000188:drug therapy / Q000276:immunology / Q000473:pathology* / Q000556:secondary; D015490:HTLV-I Infections / Q000276:immunology; D006258:Head and Neck Neoplasms / Q000188:drug therapy / Q000276:immunology / Q000473:pathology* / Q000556:secondary; D015368:Human T-lymphotropic virus 1 / Q000276:immunology*; D006801:Humans; D008207:Lymphatic Metastasis; D008209:Lymphedema / Q000209:etiology; D008297:Male; D008875:Middle Aged; D017239:Paclitaxel / Q000008:administration & dosage; D011239:Prednisolone / Q000008:administration & dosage; D012131:Respiratory Insufficiency / Q000209:etiology; D012867:Skin / Q000473:pathology; D012878:Skin Neoplasms / Q000188:drug therapy / Q000276:immunology / Q000473:pathology* / Q000556:secondary; D013964:Thyroid Neoplasms / Q000188:drug therapy / Q000276:immunology / Q000473:pathology*
D011239:Prednisolone; D016190:Carboplatin; D017239:Paclitaxel